Arizona State Retirement System lifted its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) by 6.3% in the 4th quarter, Holdings Channel reports. The fund owned 118,265 shares of the company’s stock after buying an additional 6,990 shares during the quarter. Arizona State Retirement System’s holdings in Clover Health Investments were worth $373,000 as of its most recent filing with the SEC.
Other large investors also recently added to or reduced their stakes in the company. Sigma Planning Corp bought a new position in Clover Health Investments during the third quarter worth about $29,000. KBC Group NV purchased a new stake in shares of Clover Health Investments during the 3rd quarter valued at approximately $53,000. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Clover Health Investments by 75.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock worth $3,181,000 after buying an additional 485,987 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Clover Health Investments by 5.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock valued at $8,461,000 after acquiring an additional 150,550 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Clover Health Investments during the third quarter worth $271,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.
Clover Health Investments Price Performance
CLOV stock opened at $3.66 on Friday. The firm has a 50 day simple moving average of $4.12 and a two-hundred day simple moving average of $3.62. The stock has a market cap of $1.87 billion, a PE ratio of -18.30 and a beta of 2.00. Clover Health Investments, Corp. has a one year low of $0.61 and a one year high of $4.87.
Insider Transactions at Clover Health Investments
Analysts Set New Price Targets
A number of analysts recently issued reports on CLOV shares. Craig Hallum started coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective on the stock. Canaccord Genuity Group upped their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a report on Monday, March 3rd.
Check Out Our Latest Research Report on Clover Health Investments
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Articles
- Five stocks we like better than Clover Health Investments
- 5 discounted opportunities for dividend growth investors
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Ride Out The Recession With These Dividend Kings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Technology Stocks Explained: Here’s What to Know About Tech
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report).
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.